日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comprehensive characterization of circulating tumor cells and cell-free DNA in patients with metastatic melanoma

对转移性黑色素瘤患者循环肿瘤细胞和游离DNA进行全面表征

Bos, Manouk K; Kraan, Jaco; Starmans, Martijn P A; Helmijr, Jean C A; Verschoor, Noortje; De Jonge, Maja J A; Joosse, Arjen; van der Veldt, Astrid A M; Te Boekhorst, Peter A W; Martens, John W M; Sleijfer, Stefan; Wilting, Saskia M

Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial

曲妥珠单抗联合一线紫杉烷类化疗治疗HER2阴性肿瘤但循环肿瘤细胞HER2阳性的转移性乳腺癌患者:一项II期试验

Verschoor, Noortje; Bos, Manouk K; de Kruijff, Ingeborg E; Van, Mai N; Kraan, Jaco; Drooger, Jan C; Zuetenhorst, Johanna M; Wilting, Saskia M; Sleijfer, Stefan; Jager, Agnes; Martens, John W M

Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling

转移性乳腺癌中与雌激素受体通路活性相关的基因组改变对下游ER信号传导具有不同的影响

Angus, Lindsay; Smid, Marcel; Wilting, Saskia M; Bos, Manouk K; Steeghs, Neeltje; Konings, Inge R H M; Tjan-Heijnen, Vivianne C G; van Riel, Johanna M G H; van de Wouw, Agnes J; Cpct Consortium; Cuppen, Edwin; Lolkema, Martijn P; Jager, Agnes; Sleijfer, Stefan; Martens, John W M

Apolipoprotein B mRNA-Editing Catalytic Polypeptide-Like-Induced Protein Changes in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Throughout Disease Progression

在雌激素受体阳性、人表皮生长因子受体2阴性乳腺癌疾病进展过程中,载脂蛋白B mRNA编辑催化多肽样诱导的蛋白质变化

Bos, Manouk K; Smid, Marcel; Sleijfer, Stefan; Martens, John W M

ESR1 Methylation Measured in Cell-Free DNA to Evaluate Endocrine Resistance in Metastatic Breast Cancer Patients

通过检测游离DNA中的ESR1甲基化水平来评估转移性乳腺癌患者的内分泌耐药性

Bos, Manouk K; Deger, Teoman; Sleijfer, Stefan; Martens, John W M; Wilting, Saskia M

Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA.

比较变异等位基因频率和突变分子数量作为循环肿瘤 DNA 的测量单位

Bos Manouk K, Nasserinejad Kazem, Jansen Maurice P H M, Angus Lindsay, Atmodimedjo Peggy N, de Jonge Evert, Dinjens Winand N M, van Schaik Ron H N, Del Re Marzia, Dubbink Hendrikus J, Sleijfer Stefan, Martens John W M

Retraction of: Med Acupunct. 2016;28(6):339-348; DOI: 10.1089/acu.2016.1172

撤回:Med Acupunct。 2016;28(6):339-348; DOI:10.1089/acu.2016.1172

Bos, Manouk K; Verhoeff, Sarah R; Oosting, Sjoukje F; Menke-van der Houven van Oordt, Willemien C; Boers, Ruben G; Boers, Joachim B; Gribnau, Joost; Martens, John W M; Sleijfer, Stefan; van Herpen, Carla M L; Wilting, Saskia M

Bladder preservation with brachytherapy compared to cystectomy for T1-T3 muscle-invasive bladder cancer: a systematic review

膀胱保留近距离放射治疗与膀胱切除术治疗T1-T3期肌层浸润性膀胱癌的比较:一项系统评价

Bos, Manouk K; Marmolejo, Rafael Ordoñez; Rasch, Coen R N; Pieters, Bradley R